Adding a surgery-specific module to a perioperative telemedicine programme significantly improved functional outcomes after radical prostatectomy, resulting in better urinary continence, a reduced ...

When a man receives a prostate cancer diagnosis, thoughts often race toward treatment options and survival rates. However, the recovery journey after prostate surgery represents a critical chapter ...

Dr. Catalona answers the question: 'Recovery Time After Prostatectomy?' March 16, 2009 -- Question: How long is the recovery time after laparoscopic, perineal or retropubic prostatectomy? Answer: It's ...

Pelvic floor muscle training (PFMT) and the use of duloxetine (Cymbalta) may not be the best options for recovering urinary continence after robotic-assisted radical prostatectomy, according to the ...

Men with prostate cancer have a variety of treatment choices available, including expectant management with deferred treatment, brachytherapy, external-beam radiation therapy, or both of the latter ...

DURHAM – A Durham startup focusing on improving outcomes from prostate cancer surgery now has $6.6 million in its tool chest to further advance its research and development. Levee Medical on Tuesday ...

A nerve-sparing technique (NeuroSAFE) reduced erectile dysfunction in men undergoing robot-assisted radical prostatectomy (RARP) for prostate cancer. A year after surgery, patients randomized to ...

If you're a man over age 55, you may have already had a PSA, or prostate-specific antigen test. This test screens for prostate cancer by measuring the amount of a protein in your bloodstream released ...

Please provide your email address to receive an email when new articles are posted on . Smilow Cancer Hospital has introduced a new single-port robotic prostatectomy procedure that reduces the number ...

Prostate cancer is the most common malignant tumor in men, accounting for 29% of male neoplasm diagnoses in the United States alone. Radical prostatectomy remains the preferred treatment for localized ...

PORTOS gene signature as a predictor of risk of adverse events after dose-escalated vs. lower-dose prostate radiation therapy in NRG/RTOG 0126. Five-year changes in urinary function and prostate ...